Artrite Reumatoide

Bibliografia

Quali fonti bibliografiche considerare per l’ Artrite Reumatoide?

1. Le informazioni contenute nella ricerca Pharmamedix dedicata all’artrite reumatoide sono state analizzate con riferimento alle seguenti fonti.


2. Alamanos Y., Drosos A.A., Autoimmun. Rev.,2005, 4 (3), 130.


3. Aletaha D. et al., Arthritis Rheum., 2010, 62 (9), 2569.


4. Alivernini S. et al., Immunity, 2022, 55 (12), 2255.


5. Andrade L.E. et al., Scand. J. Rheumatol., 1991, 20 (3), 204.


6. Avina-Zubieta J.A. et al., Arthritis Rheum., 2008, 59 (12), 1690.


7. Bonucci M. et al., Clinicoecon. Outcomes Res., 2016, 8, 33.


8. Cubberley C, Maharaj A., Best Pract. Res. Clin. Rheumatol., 2025, 39 (1), 102019.


9. Di Matteo A. et al., Lancet, 2023, 402 (10416), 2019.


10. D’Orazio A. et al., Clin. Exp. Rheumatol., 2024, 42 (9), 1707.


11. Díaz-González F., Hernández-Hernández M.V., Med. Clin. (Barc.), 2023, 161 (22), 533.


12. Dong Y. et al., Nutrients, 2024, 16 (23), 4050.


13. European Alliance of Associations for Rheumatology – EULAR, Updated: Managing RA, 2022 https://ard.bmj.com/content/annrheumdis/suppl/2022/12/04/ard-2022-223356.DC1/ard-2022-223356_lay_summary.pdf


14. Finckh A. et al., Nat. Rev. Rheumatol., 2022, 18, 591.


15. Firestein G.S., McInnes I.B., Immunity, 2017, 46 (2), 183.


16. Frazei G. et al., Autoimmun. rev., 2023, 22 (1), 103217.


17. Freire de Carvalho J. et al., Eur. J. Rheumatol., 2024, 11 (3), 378.


18. Gao Y. et al., MedComm (2020), 2024, 5 (3), e509.


19. Garlag D.M. et al., Ann. Rheum. Dis., 2012, 71 (5), 638.


20. Ghosh N. et al., Clinical Translational Metabolism, 2024, 22 (2), doi: https://doi.org/10.1007/s12018-024-09290-7.


21. Gibson et al., Br. J. Clin. Pharmacol, 1980, 9 (5), 453.


22. Giles I- et al., Rheumatology, 2021, 60 (8), 3565.


23. Gravallese E.M., Ann. Rheum. Dis., 2002, Suppl 2 (Suppl 2), ii84, doi: 10.1136/ard.61.suppl_2.ii84.


24. Harnden K. et al., BMJ, 2016, 352, i387.


25. Kaur C. et al., Inflammopharmacology, 2024, 32 (3), 1705.


26. Klareskog L. et al., Lancet, 2009, 373 (9664), 659.


27. Klareskog L., Alfredsson L., Immunother. Adv., 2023, 3 (1), Itad016.


28. Kobelt G. et al., Ann. Rheum. Dis., 2007, Suppl. 3 (Suppl. 3), iii35 doi: 10.1136/ard.2007.078964.


29. Li T-P. et al., RSC Adv., 2019, 9 (45), 26381.


30. Ma Y. et al., Biomark. Res., 2025, 13 (1), 47.


31. Maisha J.A. et al., Front Immunol., 2023, 14, 1221125.


32. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.


33. Mariani F.M. et al., Clin. Exp. Rheumatol., 2023, 41 (9), 1725.


34. Mathie R.T. et al., Syst. Rev., 2014, 3, 142.


35. McInnes I.B., Schett G.,NEJM, 2011, 365 (23), 2205.


36. O’Neil L.J. et al., J. Rheumatol., 2024, 51 (4), 337.


37. Pan X. et al., BMJ Open, 2017, 7 (3), e013242.


38. Peng Q. et al., Front. Pharmacol., 2025, 16, 1536023.


39. Raychaudhuri S. et al., Nat. Genet., 2012, 44 (3), 291.


40. Ruegg L. et al., Ann. Rheum. Dis., 2025, 84 (6), 910.


41. Schoels M. et al., Ann. Rheum. Dis., 2010, 69 (6), 995.


42. Scott D.L. et al., Lancet, 2010, 376 (9746), 1094.


43. Separt E. et al., Front Med. (Lausanne), 2022, 9, 1052618.


44. Smolen J.S. et al., Lancet, 2016, 388 (10055), 2023.


45. Smolen J.S. et al., Ann. Rheum. Dis., 2023, 82 (1), 3.


46. Soeken K.L. et al., Rheumatology, 2023, 42 (5), 652.


47. Toyoda T., Mankia K. Drugs, 2024, 84 (8), 895.


48. Van der Helm-van Mil A.H.M., Joint Bone Spine, 2023, 90 (4), 105543.


49. Venetsanopoulou A.I. et al., Mediterr. J. Rheumatol., 2023, 34 (4), 404.


50. Weyand C.M., Goronzy J.J, Immunol. Rev., 2020, 294 (1), 177.


51. WHO - World Health Organisation, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.


52. Ytterberg S,R. et al., NEJM, 2022, 386 (4), 316.


53. Ziembicki H. et al., Cureus, 2025, 17 (9), e93164.


54. Zhuang-Yan A., Drugs Ther. Perspect., 2025, 41, 266.